Therapeutic Asset Ratings

748 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Tozinameran Pediatric Systemic Lupus Erythematosus	National Institute of Allergy and Infectious Diseases (NIAID)	P2	CCC (50)
Tozinameran Pemphigus Vulgaris	National Institute of Allergy and Infectious Diseases (NIAID)	P2	CCC (50)
Tozinameran Rheumatoid Arthritis	National Institute of Allergy and Infectious Diseases (NIAID)	P2	CCC (50)
Tozinameran Systemic Lupus Erythematosus	National Institute of Allergy and Infectious Diseases (NIAID)	P2	CCC (50)
Tozinameran Systemic Sclerosis	National Institute of Allergy and Infectious Diseases (NIAID)	P2	CCC (50)
MODERNA COVID-19 VACCINE RNA Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Barbara Ann Karmanos Cancer Institute	P2	CCC (49)
MODERNA COVID-19 VACCINE RNA Plasma Cell Myeloma	Barbara Ann Karmanos Cancer Institute	P2	CCC (49)
Polio Vaccine Urinary Bladder Carcinoma	National Cancer Institute (NCI)	P2	CCC (49)
Adenovirus 5/F35-Human Guanylyl Cyclase C-Padre Pancreatic Ductal Adenocarcinoma	Thomas Jefferson University	P2	CCC (48)
Bacillus Calmette-Guerin Multiple Sclerosis	S. Andrea Hospital	P2	CCC (48)
Conjugated Pneumococcal Vaccine Follicular Lymphoma	H. Lee Moffitt Cancer Center and Research Institute	P2	CCC (48)
Dpx-Survivac Hepatocellular Carcinoma	ImmunoVaccine Technologies, Inc. (IMV Inc.)	P2	CCC (48)
Frame-001 Personalized Vaccine Non-Small Cell Lung Carcinoma	Frame Pharmaceuticals B.V.	P2	CCC (48)
Her-2 Pulsed Dc1 HER2 Positive Breast Carcinoma	H. Lee Moffitt Cancer Center and Research Institute	P2	CCC (48)
Mrna-1195 Multiple Sclerosis	ModernaTX, Inc.	P2	CCC (48)
ose2101 Pancreatic Ductal Adenocarcinoma	GERCOR - Multidisciplinary Oncology Cooperative Group	P2	CCC (48)
Pneumococcal 20-Valent Conjugate Vaccine Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Seema Bhat	P2	CCC (48)
Synthetic Mva-Based Sars-Cov-2 Vaccine Geo-Cm04S1 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	City of Hope Medical Center	P2	CCC (48)
Synthetic Mva-Based Sars-Cov-2 Vaccine Geo-Cm04S1 Leukemia	GeoVax, Inc.	P2	CCC (48)
Synthetic Mva-Based Sars-Cov-2 Vaccine Geo-Cm04S1 Lymphoma	GeoVax, Inc.	P2	CCC (48)
tg01 Pancreatic Ductal Adenocarcinoma	Georgetown University	P2	CCC (48)
Triadeno Vaccine Neoplasm	National Cancer Institute (NCI)	P2	CCC (48)
Tumor Lysate, Particle Only Vaccine Cancer	Elios Therapeutics, LLC	P2	CCC (48)
Ucpvax Hepatocellular Carcinoma	Centre Hospitalier Universitaire de Besancon	P2	CCC (48)
Wokvac Vaccine HER2 Positive Breast Carcinoma	H. Lee Moffitt Cancer Center and Research Institute	P2	CCC (48)

Showing 351 to 375 of 748 assets

PreviousPage 15 of 30Next